Subjects will be randomized to one of five different treatment sequences. Subjects will attend 6 scheduled visits with an expected individual duration of participation of 11 to 42 days. This study will be conducted in Australia.
The purpose of this study is to evaluate the safety profile of test formulations for an artificial tear product versus a comparator product.